HK Stock MarketDetailed Quotes

01873 VIVA BIOTECH

Watchlist
  • 0.415
  • -0.025-5.68%
Market Closed Apr 19 16:08 CST
896.97MMarket Cap-7033P/E (TTM)

VIVA BIOTECH Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
Turnover
-9.42%2.16B
3.02%1.14B
13.10%2.38B
8.02%1.11B
201.90%2.1B
419.57%1.03B
115.74%696.96M
38.79%197.56M
53.81%323.06M
--142.34M
Operating income
-9.42%2.16B
3.02%1.14B
13.10%2.38B
8.02%1.11B
201.90%2.1B
419.57%1.03B
115.74%696.96M
38.79%197.56M
53.81%323.06M
142.34M
Cost of sales
9.39%-1.42B
3.61%-736.22M
-7.63%-1.56B
-7.55%-763.78M
-270.60%-1.45B
-628.84%-710.18M
-134.53%-392.09M
-38.31%-97.44M
-59.87%-167.18M
---70.45M
Operating expenses
9.39%-1.42B
3.61%-736.22M
-7.63%-1.56B
-7.55%-763.78M
-270.60%-1.45B
-628.84%-710.18M
-134.53%-392.09M
-38.31%-97.44M
-59.87%-167.18M
-70.45M
Gross profit
-9.47%738.43M
17.68%405.97M
25.30%815.68M
9.07%344.97M
113.53%650.98M
215.90%316.28M
95.59%304.87M
39.26%100.12M
47.81%155.87M
71.89M
Selling expenses
-1.33%-132.55M
-29.57%-72.44M
-39.19%-130.8M
-61.04%-55.91M
-617.63%-93.97M
-1,679.40%-34.72M
-266.70%-13.1M
-6.21%-1.95M
9.02%-3.57M
---1.84M
Administrative expenses
-1.26%-277.11M
7.79%-131.4M
-20.92%-273.65M
-41.94%-142.5M
-105.43%-226.31M
-170.98%-100.39M
-115.10%-110.16M
-65.70%-37.05M
-100.25%-51.22M
---22.36M
Research and development expenses
5.79%-127.97M
-87.45%-76.7M
-47.04%-135.84M
-9.18%-40.92M
-39.89%-92.38M
-67.87%-37.48M
-46.91%-66.04M
-42.96%-22.32M
-78.03%-44.95M
---15.62M
Revaluation surplus
145.93%162.64M
238.90%14.22M
-293.35%-354.13M
-117.28%-10.24M
71.26%183.15M
-11.11%59.25M
-50.86%106.94M
38.39%66.66M
218.70%217.63M
--48.17M
-Changes in the fair value of financial assets
96.79%-11.68M
238.90%14.22M
-897.31%-364.18M
-117.28%-10.24M
-57.29%45.68M
-11.11%59.25M
-50.86%106.94M
38.39%66.66M
218.70%217.63M
--48.17M
-Changes in the fair value of other assets
1,634.56%174.32M
----
-92.69%10.05M
----
--137.48M
----
----
----
----
----
Impairment and provision
13.65%-8.13M
88.57%-556K
-566.03%-9.41M
-4,482.88%-4.87M
53.35%-1.41M
125.58%111K
-67.16%-3.03M
67.22%-434K
-1,503.54%-1.81M
---1.32M
-Other impairment is provision
13.65%-8.13M
88.57%-556K
-566.03%-9.41M
-4,482.88%-4.87M
53.35%-1.41M
125.58%111K
-67.16%-3.03M
67.22%-434K
-1,503.54%-1.81M
---1.32M
Operating interest expense
----
1.25%-87.98M
----
7.28%-89.1M
----
---96.1M
-2,648.08%-62.13M
----
-305.92%-2.26M
---872K
Special items of operating profit
-25.95%-234.7M
80.85%-14.36M
-268.24%-186.34M
-363.39%-74.97M
225.95%110.76M
5.31%28.47M
-25.27%33.98M
76.17%27.03M
454.68%45.47M
--15.34M
Operating profit
143.95%120.63M
149.99%36.75M
-151.71%-274.49M
-154.29%-73.52M
177.44%530.81M
2.55%135.42M
-39.29%191.33M
41.39%132.05M
149.10%315.16M
93.39M
Financing cost
4.38%-176.58M
----
-0.86%-184.67M
----
---183.11M
----
----
---38.59M
----
----
Share of profit from joint venture company
----
----
----
----
----
----
---487K
---321K
----
----
Special items of earning before tax
----
----
----
175.19%10.05M
----
97.83%-13.37M
-1,497.78%-547.05M
-1,697.79%-615.53M
-65.74%-34.24M
---34.24M
Earning before tax
87.81%-55.95M
157.90%36.75M
-232.06%-459.17M
-152.00%-63.47M
197.61%347.7M
123.36%122.05M
-226.80%-356.21M
-983.08%-522.39M
165.37%280.93M
59.16M
Tax
2.70%-43.84M
-6.19%-23.09M
4.43%-45.06M
17.16%-21.75M
-108.04%-47.14M
-233.19%-26.25M
-50.53%-22.66M
37.76%-7.88M
1.69%-15.05M
---12.66M
After-tax profit from continuing operations
80.21%-99.79M
116.03%13.66M
-267.76%-504.22M
-188.95%-85.22M
179.33%300.56M
118.07%95.8M
-242.50%-378.87M
-1,240.47%-530.27M
193.62%265.87M
46.5M
Earning after tax
80.21%-99.79M
116.03%13.66M
-267.76%-504.22M
-188.95%-85.22M
179.33%300.56M
118.07%95.8M
-242.50%-378.87M
-1,240.47%-530.27M
193.62%265.87M
46.5M
Minority profit
-32.70%16.32M
111.44%12.65M
86.38%24.26M
-44.53%5.98M
62.47%13.01M
--10.78M
--8.01M
----
----
----
Profit attributable to shareholders
78.03%-116.11M
101.11%1.01M
-283.79%-528.48M
-207.27%-91.2M
174.32%287.55M
116.03%85.02M
-245.51%-386.88M
-1,240.47%-530.27M
193.62%265.87M
46.5M
Basic earnings per share
78.57%-0.06
102.00%0.001
-286.67%-0.28
-225.00%-0.05
160.00%0.15
110.53%0.04
-231.58%-0.25
-1,050.00%-0.38
137.50%0.19
0.04
Diluted earnings per share
50.00%-0.14
102.00%0.001
-450.00%-0.28
-225.00%-0.05
132.00%0.08
110.53%0.04
-238.89%-0.25
-1,366.67%-0.38
125.00%0.18
0.03
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019
Turnover -9.42%2.16B3.02%1.14B13.10%2.38B8.02%1.11B201.90%2.1B419.57%1.03B115.74%696.96M38.79%197.56M53.81%323.06M--142.34M
Operating income -9.42%2.16B3.02%1.14B13.10%2.38B8.02%1.11B201.90%2.1B419.57%1.03B115.74%696.96M38.79%197.56M53.81%323.06M142.34M
Cost of sales 9.39%-1.42B3.61%-736.22M-7.63%-1.56B-7.55%-763.78M-270.60%-1.45B-628.84%-710.18M-134.53%-392.09M-38.31%-97.44M-59.87%-167.18M---70.45M
Operating expenses 9.39%-1.42B3.61%-736.22M-7.63%-1.56B-7.55%-763.78M-270.60%-1.45B-628.84%-710.18M-134.53%-392.09M-38.31%-97.44M-59.87%-167.18M-70.45M
Gross profit -9.47%738.43M17.68%405.97M25.30%815.68M9.07%344.97M113.53%650.98M215.90%316.28M95.59%304.87M39.26%100.12M47.81%155.87M71.89M
Selling expenses -1.33%-132.55M-29.57%-72.44M-39.19%-130.8M-61.04%-55.91M-617.63%-93.97M-1,679.40%-34.72M-266.70%-13.1M-6.21%-1.95M9.02%-3.57M---1.84M
Administrative expenses -1.26%-277.11M7.79%-131.4M-20.92%-273.65M-41.94%-142.5M-105.43%-226.31M-170.98%-100.39M-115.10%-110.16M-65.70%-37.05M-100.25%-51.22M---22.36M
Research and development expenses 5.79%-127.97M-87.45%-76.7M-47.04%-135.84M-9.18%-40.92M-39.89%-92.38M-67.87%-37.48M-46.91%-66.04M-42.96%-22.32M-78.03%-44.95M---15.62M
Revaluation surplus 145.93%162.64M238.90%14.22M-293.35%-354.13M-117.28%-10.24M71.26%183.15M-11.11%59.25M-50.86%106.94M38.39%66.66M218.70%217.63M--48.17M
-Changes in the fair value of financial assets 96.79%-11.68M238.90%14.22M-897.31%-364.18M-117.28%-10.24M-57.29%45.68M-11.11%59.25M-50.86%106.94M38.39%66.66M218.70%217.63M--48.17M
-Changes in the fair value of other assets 1,634.56%174.32M-----92.69%10.05M------137.48M--------------------
Impairment and provision 13.65%-8.13M88.57%-556K-566.03%-9.41M-4,482.88%-4.87M53.35%-1.41M125.58%111K-67.16%-3.03M67.22%-434K-1,503.54%-1.81M---1.32M
-Other impairment is provision 13.65%-8.13M88.57%-556K-566.03%-9.41M-4,482.88%-4.87M53.35%-1.41M125.58%111K-67.16%-3.03M67.22%-434K-1,503.54%-1.81M---1.32M
Operating interest expense ----1.25%-87.98M----7.28%-89.1M-------96.1M-2,648.08%-62.13M-----305.92%-2.26M---872K
Special items of operating profit -25.95%-234.7M80.85%-14.36M-268.24%-186.34M-363.39%-74.97M225.95%110.76M5.31%28.47M-25.27%33.98M76.17%27.03M454.68%45.47M--15.34M
Operating profit 143.95%120.63M149.99%36.75M-151.71%-274.49M-154.29%-73.52M177.44%530.81M2.55%135.42M-39.29%191.33M41.39%132.05M149.10%315.16M93.39M
Financing cost 4.38%-176.58M-----0.86%-184.67M-------183.11M-----------38.59M--------
Share of profit from joint venture company ---------------------------487K---321K--------
Special items of earning before tax ------------175.19%10.05M----97.83%-13.37M-1,497.78%-547.05M-1,697.79%-615.53M-65.74%-34.24M---34.24M
Earning before tax 87.81%-55.95M157.90%36.75M-232.06%-459.17M-152.00%-63.47M197.61%347.7M123.36%122.05M-226.80%-356.21M-983.08%-522.39M165.37%280.93M59.16M
Tax 2.70%-43.84M-6.19%-23.09M4.43%-45.06M17.16%-21.75M-108.04%-47.14M-233.19%-26.25M-50.53%-22.66M37.76%-7.88M1.69%-15.05M---12.66M
After-tax profit from continuing operations 80.21%-99.79M116.03%13.66M-267.76%-504.22M-188.95%-85.22M179.33%300.56M118.07%95.8M-242.50%-378.87M-1,240.47%-530.27M193.62%265.87M46.5M
Earning after tax 80.21%-99.79M116.03%13.66M-267.76%-504.22M-188.95%-85.22M179.33%300.56M118.07%95.8M-242.50%-378.87M-1,240.47%-530.27M193.62%265.87M46.5M
Minority profit -32.70%16.32M111.44%12.65M86.38%24.26M-44.53%5.98M62.47%13.01M--10.78M--8.01M------------
Profit attributable to shareholders 78.03%-116.11M101.11%1.01M-283.79%-528.48M-207.27%-91.2M174.32%287.55M116.03%85.02M-245.51%-386.88M-1,240.47%-530.27M193.62%265.87M46.5M
Basic earnings per share 78.57%-0.06102.00%0.001-286.67%-0.28-225.00%-0.05160.00%0.15110.53%0.04-231.58%-0.25-1,050.00%-0.38137.50%0.190.04
Diluted earnings per share 50.00%-0.14102.00%0.001-450.00%-0.28-225.00%-0.05132.00%0.08110.53%0.04-238.89%-0.25-1,366.67%-0.38125.00%0.180.03
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Deloitte & Touche Tohmatsu Certified Public Accountants--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg